Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Almac Group Ltd.. (2/14/17). "Press Release: RCSI and Almac Discovery Enter Research Collaboration to Target Therapy-resistant Cancer Tumours". Craigavon. 2017-02-14
Horizon Discovery Group plc. (2/14/17). "Press Release: Horizon Discovery Signs a Master Service Agreement with a Top Three Pharmaceutical Company". Cambridge. 2017-02-14
Prothena Corporation plc. (2/14/17). "Press Release: Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update". Dublin. 2017-02-14
Symbiosis Pharmaceutical Services Ltd.. (2/13/17). "Press Release: Scottish CMO Opens US Office". 2017-02-13
One Nucleus. (2/13/17). "Press Release: One Nucleus Announces New Director". Cambridge. 2017-02-13
Premaitha Health plc. (2/13/17). "Press Release: New Partnership with Major European Diagnostics Group". Manchester. 2017-02-13
Treos Bio, Ltd.. (2/13/17). "Press Release: Treos Bio Raises $8 Million in Private Investment Round". San Francisco, CA & London. 2017-02-13
Prothena Corporation plc. (2/8/17). "Press Release: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference". Dublin. 2017-02-08
Isogenica Ltd.. (2/6/17). "Press Release: Isogenica Announces New Licence Agreement with Maverick Therapeutics". Cambridge. 2017-02-06
Quotient Clinical. (2/6/17). "Press Release: Quotient Clinical Expands into USA through Acquisition of SeaView Research, the Specialist Clinical Pharmacology Business". Nottingham. 2017-02-06
AstraZeneca plc. (2/2/17). "Press Release: Full-year and Q4 2016 Results". 2017-02-02
Reading Scientific Services Ltd.. (2/2/17). "Press Release: RSSL Microbiology Laboratory Expansion". 2017-02-02
Optibrium Ltd.. (1/31/17). "Press Release: Optibrium Signs Agreement with Zastra Innovations for Distribution in India". Cambridge & Bengaluru. 2017-01-31
Heptares Therapeutics Ltd.. (1/31/17). "Press Release: Heptares Enters a New Research Collaboration under its "ORBIT" Initiative with the University of Cambridge". London & Cambridge. 2017-01-31
AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients". 2017-01-30
Qiagen N.V.. (1/30/17). "Press Release: Qiagen Hereditary and Rare Disease Solution Chosen by Genomics England". Hilden & London. 2017-01-30
Novo Nordisk A/S. (1/30/17). "Press Release: Novo Nordisk Enters Collaboration with University of Oxford on Type 2 Diabetes and Invests GBP 115m in New Research Centre". Bagsvaerd. 2017-01-30
Arcis Biotechnology Ltd.. (1/30/17). "Press Release: Arcis Biotechnology Awarded Funding under Innovate UK’s Biocatalyst Programme". Daresbury. 2017-01-30
Stallergenes Greer plc. (1/27/17). "Press Release: Stallergenes Greer Announces Positive Top-line Results of Phase 3 Study for Pediatric House Dust Mite-induced Allergic Rhinitis". 2017-01-27
Oxford BioTherapeutics Ltd.. (1/26/17). "Press Release: Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics". Alexandria, VA, San José, CA & Oxford. 2017-01-26
BioIndustry Assocation (BIA). (1/25/17). "Press Release: Innovative UK Companies Tackle Antimicrobial Resistance, Dementia and Long Term Disease Thanks to Government £26 Million Start-up Funding Awards". 2017-01-25
Horizon Discovery Group plc. (1/24/17). "Press Release: Horizon Discovery Trading Update". Cambridge. 2017-01-24
Microsaic Systems plc. (1/24/17). "Press Release: Appointment of Interim Chairman". 2017-01-24
Abzena plc. (1/20/17). "Press Release: Abzena Signs New ThioBridge License Agreement". Cambridge. 2017-01-20
GlaxoSmithKline plc. (1/19/17). "Press Release: Abbas Hussain to Leave GSK". London. 2017-01-19
GlaxoSmithKline plc. (1/19/17). "Press Release: Luke Miels Appointed President, Global Pharmaceuticals, GSK". London. 2017-01-19
Elementar UK Ltd.. (1/19/17). "Press Release: Isoprime Ltd Is Changing to Elementar UK". 2017-01-19
Congenica Ltd.. (1/17/17). "Press Release: Congenica Expands in North America with Strategic Appointment. Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer". Cambridge. 2017-01-17
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-13
Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. 2017-01-12
Intellia Therapeutics, Inc.. (1/11/17). "Press Release: Intellia Therapeutics Joins Genomics England’s Industry Consortium". Cambridge, MA & London. 2017-01-11
AstraZeneca plc. (1/10/17). "Press Release: AstraZeneca Receives EU Approval of Fasenra for Severe Eosinophilic Asthma". 2017-01-10
Macrophage Pharma Ltd.. (1/9/17). "Press Release: Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform". Windsor. 2017-01-09
Kymab Group Ltd.. (1/9/17). "Press Release: Kymab Expands Infectious Disease Programmes. Kymab Receives $9m Grant from the Bill & Melinda Gates Foundation to Fund Infectious Disease Research and Development". Cambridge. 2017-01-09
F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. 2017-01-09
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-09
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". 2017-01-06
Owlstone Medical Ltd.. (1/6/17). "Press Release: Owlstone Medical Announces $11.55m USD Fundraising". Cambridge. 2017-01-06
Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. 2017-01-05
Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
Mundipharma International Ltd.. (12/20/16). "Press Release: CHMP Announces Positive Opinion for Biosimilar Rituximab Truxima and Mundipharma Has Secured Distribution Rights". Cambridge. 2016-12-20
Microbiotica Ltd.. (12/19/16). "Press Release: Cambridge Innovation Capital plc and IP Group plc Announce the Creation of Wellcome Trust Sanger Institute Spin-out company, Microbiotica". 2016-12-19
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Bicycle Therapeutics Ltd.. (12/15/16). "Press Release: Cancer Research UK and Bicycle Therapeutics Collaborate to Trial New Therapy for Advanced Solid Tumours". London, Cambridge & Cambridge, MA. 2016-12-15
Microsaic Systems plc. (12/13/16). "Press Release: Trading Update". 2016-12-13
Oxford Nanopore Technologies Ltd.. (12/12/16). "Press Release: Oxford Nanopore Announces £100M / $126M Fundraising". Oxford. 2016-12-12
AstraZeneca plc. (12/9/16). "Press Release: US FDA Accepts First Biologics License Application for AstraZeneca’s Durvalumab in Bladder Cancer". 2016-12-09
AstraZeneca plc. (12/9/16). "Press Release: AstraZeneca and Lilly to Develop Second Potentially Disease-modifying Treatment for Alzheimer’s Disease". 2016-12-09
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Heptares Therapeutics Ltd.. (12/8/16). "Press Release: Heptares Scientists Solve Structure of CCR9 Chemokine Receptor Offering Unique Opportunity to Apply Structure-Based Design across Chemokine Receptor Family". London. 2016-12-08
AstraZeneca plc. (12/6/16). "Press Release: Tagrisso Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-positive Non-small Cell Lung Cancer". 2016-12-06
AstraZeneca plc. (12/5/16). "Press Release: AstraZeneca Completes Agreement With Cilag GmbH International for Rights to Rhinocort Aqua Outside the US". 2016-12-05
Kymab Group Ltd.. (12/5/16). "Press Release: Antibody Shows Dramatic Post-transplant Benefit". 2016-12-05
F2G Ltd.. (12/5/16). "Press Release: F2G Ltd Announces the Appointment of John H. Rex, MD, FACP to the Position of Chief Medical Officer". Manchester. 2016-12-05
Takeda Pharmaceutical Co. Ltd.. (12/2/16). "Press Release: Cerevance Launched with New Technology, Drug Portfolio and $36m in Cash to Tackle Brain Diseases". Osaka & Cambridge, MA. 2016-12-02
Bellevue Group AG. (12/2/16). "Press Release: Successful Launch of BB Healthcare Trust plc on the London Stock Exchange – Initial Issue Volume GBP 150 Million [Not for US]". 2016-12-02
Bicycle Therapeutics Ltd.. (12/1/16). "Press Release: Bicycle Therapeutics Announces Broad Partnership with AstraZeneca to Develop Bicyclic Peptides (Bicycles)". Cambridge & Cambridge, MA. 2016-12-01
Genomics plc. (12/1/16). "Press Release: Wellcome Trust Centre for Human Genetics and Genomics plc First to Sequence Multiple Human Genomes Using Hand-held Nanopore Technology". Oxford. 2016-12-01
Congenica Ltd.. (12/1/16). "Press Release: Elucigene Partners with Congenica on New NGS Cystic Fibrosis Kit". 2016-12-01
Coulter Partners. (12/1/16). "Press Release: Coulter Partners Places Chief Financial Officer for Medigene AG". 2016-12-01
Heptares Therapeutics Ltd.. (11/30/16). "Press Release: Heptares to Acquire G7 Therapeutics to Extend Leadership in GPCR-Focused Drug Discovery and Development". London & Zurich. 2016-11-30
John Wiley & Sons. (11/30/16). "Press Release: Wiley Launches New Spectra Lab Applications to Help Scientists Manage Analytical Data". 2016-11-30
Orchard Therapeutics Ltd.. (11/29/16). "Press Release: Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica". London & Oxford. 2016-11-29
International Phenome Centre Network (IPCN). (11/29/16). "Press Release: Global Research Network Hunts the Missing Link between Genetics and Environmental Factors to Unlock the Secrets of Global Diseases such as Cancer and Diabetes to Revolutionise Healt 2016-11-29
AstraZeneca plc. (11/29/16). "Press Release: AstraZeneca Takes Latest Scientific Advances in Oncology to Major US and European Congresses". 2016-11-29
Bicycle Therapeutics Ltd.. (11/28/16). "Press Release: Bicycle Therapeutics to Present Preclinical Data at the 28th EORTC-NIC-AACR Molecular Targets and Cancer Therapeutics Symposium". Cambridge, MA & Cambridge. 2016-11-28
GlaxoSmithKline plc. (11/25/16). "Press Release: GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles – Follows Regulatory Submissions in US and Canada". London. 2016-11-25
GHO Capital Partners LLP. (11/25/16). "Press Release: GHO Capital Closes €660 Million Private Equity Fund". London. 2016-11-25
Kymab Group Ltd.. (11/24/16). "Press Release: Kymab Secures US$100 Million Series C Funding". 2016-11-24
GlaxoSmithKline plc. (11/24/16). "Press Release: GSK Starts Phase III Programme with Daprodustat for Anaemia Associated with Chronic Kidney Disease". London. 2016-11-24
LIFNano Therapeutics Ltd.. (11/24/16). "Press Release: Innovative Multiple Sclerosis Treatment Receives £1m Funding Boost". 2016-11-24
GlaxoSmithKline plc. (11/23/16). "Press Release: GSK Announces Phase lll Study of Mepolizumab Meets Co-primary Endpoints and All Secondary Endpoints in Patients with Eosinophilic Granulomatosis with Polyangiitis". London. 2016-11-23
Medtech Accelerator. (11/23/16). "Press Release: Medtech Accelerator Finance Scheme Introduced in a £1.5 Million Joint Venture". 2016-11-23
Avacta Group plc. (11/23/16). "Press Release: Avacta Demonstrates Key Performance Benefits of Affimer Technology for Affinity Separation". 2016-11-23
Orchard Therapeutics Ltd.. (11/23/16). "Press Release: Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency". London. 2016-11-23
Malvern Instruments Ltd.. (11/22/16). "Press Release: Malvern and PANalytical Announce Merger". 2016-11-22
Autolus Therapeutics Ltd.. (11/22/16). "Press Release: Autolus to Manufacture at the Cell and Gene Therapy Catapult – Collaboration to Support GMP Approval and Licensure of the Centre". London. 2016-11-22
GlaxoSmithKline plc. (11/21/16). "Press Release: GSK Files Regulatory Submission in US for Once-daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD". London. 2016-11-21
Sanger Institute. (11/21/16). "Press Release: Prime Minister Opened £42m Biodata Innovation Centre and New Sequencing Facility". 2016-11-21
Horizon Discovery Group plc. (11/17/16). "Press Release: Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications". Lausanne & Cambridge. 2016-11-17
Horizon Discovery Group plc. (11/16/16). "Press Release: Horizon Discovery Enters Chinese Clinical Diagnostics Market". Cambridge. 2016-11-16
Evotec AG. (11/14/16). "Press Release: Evotec to Present at Two Upcoming IR Conferences in November". Hamburg. 2016-11-14
Evotec AG. (11/10/16). "Press Release: Evotec and Oxford Create Novel Partnership Called »LAB282«". Hamburg. 2016-11-10
Sartorius AG. (11/10/16). "Press Release: Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston". Göttingen & Boston, MA. 2016-11-10
Adaptimmune Therapeutics plc. (11/10/16). "Press Release: Adaptimmune Reports Third Quarter 2016 Financial Results". Philadeliphia, PA & Oxford. 2016-11-10
Enterprise Therapeutics Ltd.. (11/10/16). "Press Release: Enterprise Therapeutics Announces £4 million ($5 million USD) Fundraising". Brighton. 2016-11-10
Almac Group Ltd.. (11/10/16). "Press Release: Almac Group Announce £27 million Global Expansion. Global Headcount Set to Reach 5,000 by 2017". Craigavon. 2016-11-10
Affimed N.V.. (11/9/16). "Press Release: Affimed to Present at the Jefferies 2016 London Healthcare Conference". Heidelberg. 2016-11-09
Tecan Group Ltd.. (11/9/16). "Press Release: Tecan to Present at Jefferies 2016 London Healthcare Conference". Männedorf. 2016-11-09
Horizon Discovery Group plc. (11/9/16). "Press Release: Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing". Cambridge. 2016-11-09
Ablynx N.V.. (11/9/16). "Press Release: Ablynx to Present at the Jefferies London Healthcare Conference 2016". Ghent. 2016-11-09
Oxford Nanopore Technologies Ltd.. (11/3/16). "Press Release: Oxford Nanopore Responds to the Patent Lawsuit Filed by Pacific Biosciences". 2016-11-03
Neovacs S.A.. (11/3/16). "Press Release: Neovacs to Attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016". Paris & Boston, MA. 2016-11-03
Bruker Corporation. (11/2/16). "Press Release: Bruker Announces Acquisition of Nucleic Acid Testing (NAT) Assays and Syndromic Panel Technology to Expand its MALDI Biotyper Platform". Billerica. 2016-11-02
Owlstone Medical. (11/1/16). "Press Release: Owlstone Medical and Imperial College Collaborate to Study Underlying Causes of Asthma Exacerbations". Cambridge. 2016-11-01
Bruker Corporation. (11/1/16). "Press Release: Bruker Bio AFM Enables Advanced DNA Research at University of Leeds". Santa Barbara, CA. 2016-11-01
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top